Skip to main content
Clinical Trials/ACTRN12623000132640
ACTRN12623000132640
Active, not recruiting
未知

Comparison of the efficacy of Botulinum Toxin injection in masseter muscles versus in the lateral pterygoid and temporalis muscles for the management of TMJ myofacial pain.

Damascus University0 sites26 target enrollmentFebruary 8, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Myofascial Pain - Dysfunction Syndrome of TMJ
Sponsor
Damascus University
Enrollment
26
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 8, 2023
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with myofacial pain according to RDC\-TMD axis I.
  • \-The pain intense on VAS is more than 5\.
  • \- Bruxism.
  • \- Mild teeth wear include the centrals and canines.
  • \- Limited mouth opening due to muscles spasm.

Exclusion Criteria

  • \- Patients known to be allergic to any botulinum toxin.
  • \- Patients who underwent any botulinum toxin type A treatment in less than six months
  • \- Pregnant or breastfeeding women.
  • \- Patients addicted to narcotic drugs or alcohol.
  • \- Patients with depression and/or somatization according to RDC\-TMD axis II.
  • \- People with neurological disorders.
  • \- Patients taking aminoglycosides.
  • \- Active infection at the injection site.

Outcomes

Primary Outcomes

Not specified

Similar Trials